10 studies found for:    99mTc-MDP
Show Display Options
Rank Status Study
1 Completed Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
Conditions: Bone Metastases;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Procedure: magnetic resonance imaging;   Radiation: fluorine F 18 sodium fluoride;   Procedure: positron emission tomography;   Procedure: computed tomography;   Radiation: technetium Tc 99m methylene diphosphonate;   Other: laboratory biomarker analysis
2 Unknown  F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
Conditions: Cancer;   Bone Metastases
Interventions: Device: F-18 PET bone scan;   Device: Tc-99m bone scan
3 Completed
Has Results
Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: teriparatide
4 Unknown  18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
Condition: Cancer
Intervention:
5 Recruiting F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
Condition: Bone Metastases
Intervention: Device: Bone Scan: F18-Fluoride PET/CT or TC-MDP
6 Recruiting Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone
Condition: Bone Scan
Intervention: Other: 18F-Sodium Fluoride (Na18F)
7 Recruiting PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases
Condition: Cancer
Interventions: Procedure: F-18 NaF/F-18 FDG PET/CT;   Procedure: Whole-body MRI;   Procedure: Tc-99m MDP bone scan
8 Unknown  F18-Flouride PET/CT in Acute Knee Injury
Condition: Knee Injury
Intervention:
9 Recruiting 18F-NaF PET Imaging for Bone Scintigraphy
Condition: Bone Metastases From Breast or Prostate Cancer
Interventions: Procedure: NaF PET/CT Imaging;   Procedure: 99mTc-medronate whole body bone scan with SPECT;   Drug: 18F-NaF (185-370 MBq)
10 Recruiting 18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
Conditions: Breast Cancer;   18F-FDG PET
Intervention:

Indicates status has not been verified in more than two years